Follow Us On

  • Facebook


Import Substitution And Innovation Programs In The Field Of Pharmaceutics Will Be Discussed In The Framework Of The Biotechmed Conference In September

 On the eve of the conference "Biotechmed", which will be held September 14-15 in Gelendzhik, a press event dedicated to the prospects of the biotechnology industry was held. Deputy Minister of Industry and Trade of the Russian Federation Sergey Tsyb , Deputy Minister of Health of the Russian Federation Sergey Kraevoy , Deputy Minister of Agriculture of the Russian Federation Elena Astrakhantseva , Executive Director of the State Corporation Rostek Oleg Evtushenko told about the main topics of the forthcoming event .

The development of biotechnologies is a complex task that concerns many sectors of the economy. According to Sergei Tsyb , the pharmaceutical industry has made serious steps to create its own competencies in this segment.

"Before the implementation of" Farma-2020 ", we practically did not produce modern biotechnological products. According to the results of the first half of 2017, in the segment of "7 nosologies", more than 30% of Russian drugs are in money terms, "the deputy head of the Ministry of Industry and Trade of Russia said . - This indicates that we have created competencies, replaced complex drugs. For example, we produce the entire group of monoclonal antibodies, all recombinant blood factors. State corporation "Rostekh" together with "Pharmstandard" will create in Kirov manufacture of plasma factors of blood ".

The implementation of the Kirov project will allow to remove the import dependence in this segment of drugs. Against the backdrop of the growing volume of the pharmaceutical market, Russian industry is gradually increasing its presence. 

We are quite actively developing the pharmaceutical industry. According to the results of the first half of 2017, the market volume grew by more than 10%, the growth in the volume of production of medicines in Russia over the same period compared to 2016 was 11.2%

Said Sergei Tsyb.

Measures to further stimulate import substitution programs, develop their own innovative products will be discussed at the Biotechmed conference.

This year, within its framework, the Ministry of Industry and Trade of Russia organizes a number of new events. One of them is the Project Rally. Research institutes, centers, universities, Russian companies will present their innovative projects in the pharmaceutical industry to potential investors and business partners.

"We believe that potential investors will be involved in this event, a collaboration between companies will be created that will allow these projects to be transferred to the commercialization area, " the deputy head of the Ministry of Industry and Trade of Russia said.

During the conference "Biotechmed" the topics of development of production of innovative medical equipment, products in the field of traumatology and orthopedics, questions of regulation of the circulation of pharmaceutical and medical products will also be touched upon. According to the leadership of the Ministry, the event will allow full use of all resources to ensure the further development of biotechnology. 

© Copyright 2010-16 Invest in Russia Hanko Hackberry Group All rights reserved.